Physician profile
Felice Colliton
NPI 1033212121
$1,925.55
in general payments reported to CMS, 2019-2025
23 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $144 · 2021: $262 · 2022: $83.90 · 2023: $356 · 2024: $650 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,168.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $266.34 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $217.98 | 2023-2024 | Veozah |
| Mayne Pharma Commercial LLC | $216.37 | 2022-2025 | |
| Avion Pharmaceuticals | $170.23 | 2019-2021 | |
| Exact Sciences Corporation | $151.74 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $131.46 | 2021-2025 | |
| Therapeuticsmd, INC. | $106.81 | 2019-2021 | |
| Agile Therapeutics, INC. | $99.53 | 2021-2024 | Twirla |
| Exeltis, USA INC. | $80.34 | 2019-2024 | Slynd |
| Millicent US INC | $79.47 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Sumitomo Pharma America, INC. | $75.05 | 2023-2024 | Myfembree |
| Coopersurgical, INC. | $68.46 | 2024 | Paragard T 380a |
| Merck Sharp & Dohme LLC | $51.93 | 2019-2024 | Gardasil 9, Gardasil |
| Myovant Sciences INC. | $39.04 | 2022 | |
| Amag Pharmaceuticals, INC. | $31.33 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $29.40 | 2025 | Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $22.14 | 2023 | |
| Sage Therapeutics, LLC | $18.19 | 2024 | |
| Conmed Corporation | $17.31 | 2024 | Airseal |
| Organon LLC | $15.69 | 2023 | Nexplanon |
| Medicem INC. | $13.95 | 2021 | |
| Evofem Biosciences, INC. | $11.66 | 2021 | |
| Minerva Surgical, INC | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felice Colliton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.